Human Anti-Wrinkle Efficacy Testing: Methods, Parameters, and Applications for Cosmetic Products

Human anti-wrinkle efficacy testing is an in vivo clinical evaluation designed to verify whether skincare products genuinely reduce the appearance of wrinkles on human skin. By combining instrumental analysis such as 3D skin imaging and skin profilometry with dermatologist grading and self-assessment, this testing generates scientifically valid evidence required for cosmetic efficacy claims, regulatory filing, and product marketing support.

Technical Overview

Human anti-wrinkle efficacy testing (in vivo wrinkle reduction testing) is a clinical study conducted on human volunteers to objectively measure changes in skin wrinkles and skin texture following the regular use of a test product. The evaluation is typically performed on facial areas prone to wrinkle formation, such as the corners of the eyes (crow's feet), the forehead, and the nasolabial region, where fine lines and wrinkles are visually prominent.

The core principle of the test is a self-controlled, before-and-after comparison. Baseline measurements are recorded prior to product application, and the same skin sites are re-measured at defined intervals, commonly 14 days, 28 days, and 56 days. A statistically significant improvement in wrinkle parameters compared with baseline demonstrates the anti-wrinkle efficacy of the product.

In China, this type of human efficacy testing is governed by the Standards for Efficacy Claim Evaluation of Cosmetics, which require that products claiming wrinkle improvement or firming effects be substantiated through human efficacy trials published in referenced literature or conducted under documented test protocols. Internationally, the methodology aligns with EEMCO guidance on skin topography measurement and ISO standards for in vivo cosmetic efficacy testing, ensuring that results are accepted across global markets.

Testing Samples

Facial Anti-Aging Products

The most frequently submitted samples include anti-wrinkle creams, firming lotions, eye creams and eye serums targeting crow's feet, essences and ampoules with peptide or retinoid actives, overnight masks, and facial oils with anti-wrinkle positioning. These leave-on products are applied according to the recommended consumer usage instructions.

Functional and Supporting Products

Additional sample categories include neck and décolletage creams, anti-aging facial masks, foundation and BB creams with skincare claims, sunscreen products claiming photoaging protection, and cosmetic devices used in combination with topical formulations. For multi-step regimens, the complete routine or the key single product may be evaluated depending on the claim to be substantiated.

Active Ingredients and Formulations in Development

Raw material suppliers and formulators also submit candidate actives, prototype formulations, and reformulated products for comparative testing, allowing quantitative comparison of wrinkle improvement between new and reference formulations before commercialization.

Testing Items

Anti-wrinkle efficacy is characterized through a combination of quantitative morphological parameters, biomechanical properties, and clinical evaluations:

• Wrinkle area ratio: the proportion of the analyzed skin region occupied by wrinkles, reflecting overall wrinkle coverage.
• Wrinkle count and total wrinkle length: the number of wrinkle lines and their cumulative length within the target area.
• Average and maximum wrinkle depth: vertical depth values captured by 3D optical profiling, directly indicating wrinkle severity.
• Wrinkle volume: the three-dimensional volume of wrinkle indentations, a sensitive indicator of improvement in deeper lines.
• Skin surface roughness parameters: profilometric values such as Ra, Rz, Rq, and Rt that describe skin micro-texture and smoothness.
• Skin elasticity and firmness: Cutometer parameters including overall elasticity (R2), net elasticity (R5), and biological elasticity relative to viscoelastic ratio (R7), which correlate with structural support of the skin.
• Skin hydration: corneometer readings often included as a supporting mechanism indicator for superficial fine-line improvement.
• Dermatologist clinical grading: standardized visual scoring of wrinkle severity using validated scales, typically 0 to 9, performed by trained assessors under standardized lighting.
• Subject self-assessment: questionnaire results on perceived wrinkle reduction, skin smoothness, and overall satisfaction.

Testing Methods

Study Design and Volunteer Recruitment

Testing follows a self-controlled design in which each subject serves as their own baseline. In accordance with Chinese efficacy evaluation requirements, a minimum of 30 valid subjects per test group is required for human efficacy trials. Volunteers are healthy adults, typically aged 30 to 65, presenting visible fine lines or wrinkles in the target areas. Inclusion and exclusion criteria screen out factors that could confound results, such as recent use of retinoid medication, aesthetic injection procedures, laser treatment, severe skin diseases, pregnancy, or lactation. All participants sign informed consent forms, and the study protocol is reviewed in accordance with ethical principles for research involving human subjects.

Acclimatization and Baseline Measurement

Before baseline capture, subjects rest for at least 30 minutes in a controlled environment maintained at approximately 20 to 22 degrees Celsius with relative humidity of 40 to 60 percent. Facial makeup is removed, and the skin is allowed to equilibrate. Baseline imaging and instrumental measurements are then performed on marked target sites, usually one on each side of the face for paired observation, ensuring that the identical site is re-measured at each follow-up visit through positioning guides or facial registration software.

Instrumental Measurement Techniques

• 3D skin surface imaging: Optical systems such as fringe projection or structured-light profilometers generate high-resolution three-dimensional maps of the skin surface, from which wrinkle depth, volume, area, and roughness parameters are computed with micron-level precision.
• Clinical photography systems: Instruments such as VISIA-CR capture standardized cross-polarized, parallel-polarized, and UV-exposed images under reproducible lighting and positioning, enabling visual documentation and image-analysis-based quantification of fine lines and skin texture.
• Skin replicas with laboratory profilometry: Silicone impressions of the skin surface are cast in vivo and subsequently analyzed offline using optical or mechanical profilometry, providing validated roughness parameters for the replicated area.
• Suction-based elastometry: The Cutometer applies controlled negative pressure to the skin and records the deformation-time curve, deriving elasticity parameters R2, R5, and R7 that reflect dermal structural improvement.
• Handheld optical scanners: Compact devices such as the Antera 3D provide rapid in-clinic quantification of wrinkle depth, volume, and skin texture with co-registered positioning.

Product Application Protocol

Subjects apply the test product at home according to a standardized regimen, for example twice daily on cleansed facial skin in a specified dose of approximately 2 mg per square centimeter, for a continuous period of 28 days with an optional extension to 56 days. Compliance is monitored through application logs, remaining-product weighing, and periodic check-in visits. Use of other anti-aging products in the target area is prohibited during the study.

Follow-Up Visits and Data Collection

Instrumental measurements, standardized photography, dermatologist grading, and self-assessment questionnaires are repeated at intermediate and final time points, commonly day 14, day 28, and day 56. Identical environmental conditions, equipment settings, and site positioning are maintained throughout the study to ensure comparability of longitudinal data.

Statistical Analysis

Changes from baseline are analyzed using paired-sample t-tests for normally distributed data or Wilcoxon signed-rank tests for non-parametric data, with significance set at a p-value below 0.05. Results are reported as absolute and percentage changes with confidence intervals, and efficacy is concluded only when statistically significant improvement in key wrinkle parameters is demonstrated with an adequate sample size.

Applications

Human anti-wrinkle efficacy testing serves multiple critical purposes across the cosmetics value chain:

• Regulatory compliance: Generating the human efficacy test evidence required for cosmetics filing and registration of wrinkle-smoothing and firming claims in China and for substantiating claims under EU Regulation 655/2013 common criteria.
• Marketing claim support: Providing quantitative proof points such as measurable reduction in wrinkle depth or area percentage after 28 days of use, suitable for advertising, e-commerce detail pages, and product launch materials.
• Formulation optimization: Enabling R&D teams to compare prototype formulations, active concentrations, and delivery systems quantitatively during development.
• Competitive benchmarking: Demonstrating superior or equivalent performance of a test product against a market-leading reference under identical test conditions.
• Ingredient substantiation: Allowing raw material suppliers to build efficacy dossiers for functional actives such as peptides, retinoids, niacinamide, and plant extracts.
• Consumer confidence: Reinforcing brand credibility through transparent, third-party or in-house clinical evidence of product performance.

FAQ

How long does a complete anti-wrinkle efficacy test take?

A standard 28-day study, including volunteer recruitment, screening, baseline measurement, the product-use period, follow-up visits, and report issuance, typically requires approximately two to three months. Studies extended to 56 days may require three to four months in total.

How many volunteers are required for the test?

Chinese efficacy evaluation requirements specify a minimum of 30 valid subjects for human efficacy trials. Larger panels of 50 or more subjects may be used to strengthen statistical power, particularly for claims intended for international markets.

Which facial areas are most commonly tested?

The corners of the eyes, specifically the crow's feet region, are the most frequently selected site because wrinkles there are highly reproducible and visually significant. The forehead and nasolabial fold areas are also common targets, and the test site is chosen according to the product type and intended claim.

What is the difference between instrumental measurement and clinical grading?

Instrumental measurement provides objective, quantitative data such as wrinkle depth in micrometers, while clinical grading captures the dermatologist's holistic visual assessment using validated scoring scales. Combining both methods, together with self-assessment questionnaires, produces a comprehensive and defensible efficacy conclusion.

Can the test results be used directly in advertising claims?

Yes, when the study is conducted under a documented protocol with statistically significant results, quantified outcomes such as a percentage reduction in wrinkle area may be cited in claims, provided the wording accurately reflects the test conditions, duration, sample size, and measured endpoints.

Is a control group or untreated area required?

The standard design is self-controlled, comparing each subject's post-treatment values with their own baseline. For stronger evidence, a paired-site design or a placebo-controlled or reference-product-controlled parallel design may be added to separate active effects from environmental influences.